2-aminoguanidine carbonic acid

We are 2-aminoguanidine carbonic acid CAS:2200-97-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 2200-97-7
Product Name: 2-aminoguanidine carbonic acid
Other Name:
2-aminoguanidine carbonic acid
aminoguanidine carbonate
Aminoguanidine hydrogen carbonate
2-aminoguanidinium bicarbonate
aminoguanidine carbonic acid salt
Aminoguanidinium bicarbonate
Aminoguanidium hydrogen carbonate
Guanylhydrazine bicarbonate
Aminoguanidine hydrocarbonate
1-Aminoguanidine bicarbonate
 
Boiling Point: 261.4ºC at 760mmHg
Molecular Formula: C2H8N4O3
Molecular Weight: 136.11000
Flash Point: 111.9ºC
Exact Mass: 136.06000
PSA: 145.45000
LogP: 0.45680
 
Specification
Appearance: White crystalline powder 
Assay: ≥99.0%
Insoluble substance: ≤0.03%
Water: ≤0.2%
Ignition residue: ≤0.07%
Chlorides (Cl): ≤0.01%
Iron content (Fe): ≤8ppm
Sulfates (SO4): ≤0.007%
 
Application
Intermediates of Mitoguazone CAS: 459-86-9.
Be used as pharmaceutical intermediate, mainly used in the synthesis of the adult acute myeloid leukemia and malignant lymphoma drug Mitoguazone.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2-aminoguanidine carbonic acid


Related News: Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.(2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone CAS:915095-87-3 The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.189005-44-5 Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.Ácido (4S) -2-oxo-3-fenilmetoxicarbonilimidazolidina-4-carboxílico CAS:59760-01-9 Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI).

Related Products
Product Name
1-Bromo-4-chloronaphthalene View Details
BABPA-B View Details
7-Methoxy-1-tetralone View Details
N-Methyl-L-valine manufacturer L-Norleucine manufacturer 4,6-difluoro-1H-indole-2-carboxylic acid manufacturer 3-Methacryloxypropyltrimethoxysilane manufacturer N-Boc-L-Glutamic Acid dimethyl ester manufacturer